In a regulatory filing, Sun Pharmaceutical Industries said its
"wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous
Injection 100 mg Syringe in Japan for the treatment of plaque
psoriasis in adult patients who have an inadequate response to
conventional therapies".
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-arm-launches-plaque-psoriasis-treatment-drug-in-japan/articleshow/78269005.cms
No comments:
Post a Comment